Triple-negative breast cancer (TNBC) is a term coined to define a group of breast cancers lacking the expression of an estrogen receptor (ER), a progesterone receptor (PR), and a human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.